dc.contributor.author |
Carroll Chapman, Shawna L |
|
dc.contributor.author |
Wu, Li-Tzy |
|
dc.date.accessioned |
2020-02-03T04:43:00Z |
|
dc.date.available |
2020-02-03T04:43:00Z |
|
dc.date.issued |
2012-07 |
|
dc.identifier |
S0891-4222(12)00037-6 |
|
dc.identifier.issn |
0891-4222 |
|
dc.identifier.issn |
1873-3379 |
|
dc.identifier.uri |
https://hdl.handle.net/10161/19964 |
|
dc.description.abstract |
Individuals with disabilities are a growing population that confronts multiple disadvantages
from social and environmental determinants of health. In particular, the 7-8 million
people in the U.S. with an intellectual disability (ID) suffer disproportionately
from substance use problems, largely because of a lack of empirical evidence to inform
prevention and treatment efforts for them. Although available research could inform
future research efforts, studies are scattered across disciplines with the last review
synthesizing findings written more than five years ago. To consider more recent findings
with earlier works, PubMed, PsychINFO, and Google Scholar were searched and produced
37 peer-reviewed texts across multiple disciplines, 15 from 2006 or later. While the
prevalence of alcohol and illicit drug use in this population are low, the risk of
having a substance-related problem among ID substance users is comparatively high.
Gaps in the research and population subgroups that warrant special attention are identified,
such as individuals with borderline and mild ID, individuals with co-occurring mental
illness, and individuals who are incarcerated. Compared with substance abusers without
ID, ID substance abusers are less likely to receive substance abuse treatment or remain
in treatment. Research is needed to better gauge the magnitude of substance use problems,
identify prevention strategies, and specify treatment components that meet the unique
needs of individuals with ID.
|
|
dc.language |
eng |
|
dc.publisher |
Elsevier BV |
|
dc.relation.ispartof |
Research in developmental disabilities |
|
dc.relation.isversionof |
10.1016/j.ridd.2012.02.009 |
|
dc.subject |
Humans |
|
dc.subject |
Substance-Related Disorders |
|
dc.subject |
Prevalence |
|
dc.subject |
Risk Factors |
|
dc.subject |
Intellectual Disability |
|
dc.title |
Substance abuse among individuals with intellectual disabilities. |
|
dc.type |
Journal article |
|
duke.contributor.id |
Wu, Li-Tzy|0380644 |
|
dc.date.updated |
2020-02-03T04:43:00Z |
|
pubs.begin-page |
1147 |
|
pubs.end-page |
1156 |
|
pubs.issue |
4 |
|
pubs.organisational-group |
School of Medicine |
|
pubs.organisational-group |
Duke |
|
pubs.organisational-group |
Center for Child and Family Policy |
|
pubs.organisational-group |
Sanford School of Public Policy |
|
pubs.organisational-group |
Duke Clinical Research Institute |
|
pubs.organisational-group |
Institutes and Centers |
|
pubs.organisational-group |
Duke Institute for Brain Sciences |
|
pubs.organisational-group |
University Institutes and Centers |
|
pubs.organisational-group |
Institutes and Provost's Academic Units |
|
pubs.organisational-group |
Psychiatry & Behavioral Sciences, Social and Community Psychiatry |
|
pubs.organisational-group |
Psychiatry & Behavioral Sciences |
|
pubs.organisational-group |
Clinical Science Departments |
|
pubs.organisational-group |
Medicine, General Internal Medicine |
|
pubs.organisational-group |
Medicine |
|
pubs.publication-status |
Published |
|
pubs.volume |
33 |
|
duke.contributor.orcid |
Wu, Li-Tzy|0000-0002-5909-2259 |
|